These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 18802816)

  • 1. Immunotoxicity of perfluorooctanoic acid and perfluorooctane sulfonate and the role of peroxisome proliferator-activated receptor alpha.
    DeWitt JC; Shnyra A; Badr MZ; Loveless SE; Hoban D; Frame SR; Cunard R; Anderson SE; Meade BJ; Peden-Adams MM; Luebke RW; Luster MI
    Crit Rev Toxicol; 2009; 39(1):76-94. PubMed ID: 18802816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription of genes involved in fat metabolism in chicken embryos exposed to the peroxisome proliferator-activated receptor alpha (PPARα) agonist GW7647 or to perfluorooctane sulfonate (PFOS) or perfluorooctanoic acid (PFOA).
    Strömqvist M; Olsson JA; Kärrman A; Brunström B
    Comp Biochem Physiol C Toxicol Pharmacol; 2012 Jun; 156(1):29-36. PubMed ID: 22465071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of mouse and human peroxisome proliferator-activated receptors (alpha, beta/delta, gamma) by perfluorooctanoic acid and perfluorooctane sulfonate.
    Takacs ML; Abbott BD
    Toxicol Sci; 2007 Jan; 95(1):108-17. PubMed ID: 17047030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro evaluation of the immunotoxic potential of perfluorinated compounds (PFCs).
    Corsini E; Avogadro A; Galbiati V; dell'Agli M; Marinovich M; Galli CL; Germolec DR
    Toxicol Appl Pharmacol; 2011 Jan; 250(2):108-16. PubMed ID: 21075133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotoxicity of perfluorinated compounds: recent developments.
    DeWitt JC; Peden-Adams MM; Keller JM; Germolec DR
    Toxicol Pathol; 2012; 40(2):300-11. PubMed ID: 22109712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developmental toxicity of perfluorooctane sulfonate (PFOS) is not dependent on expression of peroxisome proliferator activated receptor-alpha (PPAR alpha) in the mouse.
    Abbott BD; Wolf CJ; Das KP; Zehr RD; Schmid JE; Lindstrom AB; Strynar MJ; Lau C
    Reprod Toxicol; 2009 Jun; 27(3-4):258-265. PubMed ID: 18595657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating the additivity of perfluoroalkyl acids in binary combinations on peroxisome proliferator-activated receptor-α activation.
    Wolf CJ; Rider CV; Lau C; Abbott BD
    Toxicology; 2014 Feb; 316():43-54. PubMed ID: 24374136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of mouse and human peroxisome proliferator-activated receptor-α in modulating the hepatic effects of perfluorooctane sulfonate in mice.
    Su S; Billy LJ; Chang S; Gonzalez FJ; Patterson AD; Peters JM
    Toxicology; 2022 Jan; 465():153056. PubMed ID: 34861291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for the involvement of xenobiotic-responsive nuclear receptors in transcriptional effects upon perfluoroalkyl acid exposure in diverse species.
    Ren H; Vallanat B; Nelson DM; Yeung LWY; Guruge KS; Lam PKS; Lehman-McKeeman LD; Corton JC
    Reprod Toxicol; 2009 Jun; 27(3-4):266-277. PubMed ID: 19162173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The atrophy and changes in the cellular compositions of the thymus and spleen observed in mice subjected to short-term exposure to perfluorooctanesulfonate are high-dose phenomena mediated in part by peroxisome proliferator-activated receptor-alpha (PPARalpha).
    Qazi MR; Xia Z; Bogdanska J; Chang SC; Ehresman DJ; Butenhoff JL; Nelson BD; DePierre JW; Abedi-Valugerdi M
    Toxicology; 2009 Jun; 260(1-3):68-76. PubMed ID: 19464571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling in the liver and lung of perfluorooctane sulfonate-exposed mouse fetuses: comparison to changes induced by exposure to perfluorooctanoic acid.
    Rosen MB; Schmid JE; Das KP; Wood CR; Zehr RD; Lau C
    Reprod Toxicol; 2009 Jun; 27(3-4):278-288. PubMed ID: 19429403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Perfluorooctane sulfonate (PFOS) toxicity in domestic chicken (Gallus gallus domesticus) embryos in the absence of effects on peroxisome proliferator activated receptor alpha (PPARalpha)-regulated genes.
    O'Brien JM; Carew AC; Chu S; Letcher RJ; Kennedy SW
    Comp Biochem Physiol C Toxicol Pharmacol; 2009 May; 149(4):524-30. PubMed ID: 19101656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. trans-activation of PPARalpha and induction of PPARalpha target genes by perfluorooctane-based chemicals.
    Shipley JM; Hurst CH; Tanaka SS; DeRoos FL; Butenhoff JL; Seacat AM; Waxman DJ
    Toxicol Sci; 2004 Jul; 80(1):151-60. PubMed ID: 15071170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perfluoroalkyl acids-induced liver steatosis: Effects on genes controlling lipid homeostasis.
    Das KP; Wood CR; Lin MT; Starkov AA; Lau C; Wallace KB; Corton JC; Abbott BD
    Toxicology; 2017 Mar; 378():37-52. PubMed ID: 28049043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplicity of nuclear receptor activation by PFOA and PFOS in primary human and rodent hepatocytes.
    Bjork JA; Butenhoff JL; Wallace KB
    Toxicology; 2011 Oct; 288(1-3):8-17. PubMed ID: 21723365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Perfluorooctanoic acid induced-developmental cardiotoxicity: are peroxisome proliferator activated receptor α (PPARα) and bone morphorgenic protein 2 (BMP2) pathways involved?
    Jiang Q; Lust RM; DeWitt JC
    J Toxicol Environ Health A; 2013; 76(11):635-50. PubMed ID: 23941634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.
    Rosen MB; Das KP; Rooney J; Abbott B; Lau C; Corton JC
    Toxicology; 2017 Jul; 387():95-107. PubMed ID: 28558994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid peroxidation and oxidative stress responses of salmon fed a diet containing perfluorooctane sulfonic- or perfluorooctane carboxylic acids.
    Arukwe A; Mortensen AS
    Comp Biochem Physiol C Toxicol Pharmacol; 2011 Nov; 154(4):288-95. PubMed ID: 21742055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of antigen-specific antibody responses in mice exposed to perfluorooctanoic acid: Role of PPARα and T- and B-cell targeting.
    DeWitt JC; Williams WC; Creech NJ; Luebke RW
    J Immunotoxicol; 2016; 13(1):38-45. PubMed ID: 25594567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perfluorooctanoic Acid (PFOA)-induced Liver Lesions in Two Strains of Mice Following Developmental Exposures: PPARα Is Not Required.
    Filgo AJ; Quist EM; Hoenerhoff MJ; Brix AE; Kissling GE; Fenton SE
    Toxicol Pathol; 2015 Jun; 43(4):558-68. PubMed ID: 25398757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.